Carol Markey

998 total citations
15 papers, 597 citations indexed

About

Carol Markey is a scholar working on Neurology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carol Markey has authored 15 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carol Markey's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers) and Prostate Cancer Treatment and Research (4 papers). Carol Markey is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers) and Prostate Cancer Treatment and Research (4 papers). Carol Markey collaborates with scholars based in United States, Israel and Finland. Carol Markey's co-authors include Sanford P. Markey, Elizabeth M. Gillanders, Derek Gildea, Erica L. Riedesel, Julie Albertus, Diana Freas‐Lutz, Moussa B. H. Youdim, Qiuhe Cao, Hiroya Ikeda and Anibal Cravchik and has published in prestigious journals such as Annals of Neurology, Brain Research and The FASEB Journal.

In The Last Decade

Carol Markey

15 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Markey United States 12 229 185 165 128 96 15 597
Partha Narayan Dey India 8 91 0.4× 254 1.4× 87 0.5× 148 1.2× 21 0.2× 10 469
Hisashi Nakamura Japan 13 77 0.3× 235 1.3× 107 0.6× 203 1.6× 80 0.8× 32 680
Judith Mallolas Spain 9 85 0.4× 291 1.6× 41 0.2× 136 1.1× 27 0.3× 13 547
Dörte Otto Germany 7 99 0.4× 273 1.5× 28 0.2× 359 2.8× 74 0.8× 10 617
Steven B. Condliffe Italy 14 147 0.6× 482 2.6× 91 0.6× 226 1.8× 234 2.4× 17 904
Elena Amendola Italy 18 485 2.1× 687 3.7× 53 0.3× 135 1.1× 26 0.3× 31 1.1k
Valerija Dobričić Germany 14 86 0.4× 316 1.7× 40 0.2× 113 0.9× 120 1.3× 40 641
B. Lutz‐Bucher France 17 63 0.3× 345 1.9× 101 0.6× 309 2.4× 113 1.2× 53 1.0k
Masaharu Hayashi Japan 17 102 0.4× 478 2.6× 16 0.1× 89 0.7× 112 1.2× 40 752
Konstantín L. Levitsky Spain 11 135 0.6× 285 1.5× 49 0.3× 104 0.8× 10 0.1× 12 543

Countries citing papers authored by Carol Markey

Since Specialization
Citations

This map shows the geographic impact of Carol Markey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Markey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Markey more than expected).

Fields of papers citing papers by Carol Markey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Markey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Markey. The network helps show where Carol Markey may publish in the future.

Co-authorship network of co-authors of Carol Markey

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Markey. A scholar is included among the top collaborators of Carol Markey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Markey. Carol Markey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rökman, Annika, Agnes Baffoe‐Bonnie, Elizabeth M. Gillanders, et al.. (2004). Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Human Genetics. 116(1-2). 43–50. 19 indexed citations
2.
3.
Xu, Jianfeng, Elizabeth M. Gillanders, Sarah D. Isaacs, et al.. (2003). Genome‐wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families. The Prostate. 57(4). 320–325. 53 indexed citations
4.
Wiklund, Fredrik, Elizabeth M. Gillanders, Julie Albertus, et al.. (2003). Genome‐wide scan of Swedish families with hereditary prostate cancer: Suggestive evidence of linkage at 5q11.2 and 19p13.3. The Prostate. 57(4). 290–297. 46 indexed citations
5.
Schleutker, Johanna, Agnes Baffoe‐Bonnie, Elizabeth M. Gillanders, et al.. (2003). Genome‐wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25‐26. The Prostate. 57(4). 280–289. 37 indexed citations
6.
Cao, Qiuhe, María Martínez, Jing Zhang, et al.. (1997). Suggestive Evidence for a Schizophrenia Susceptibility Locus on Chromosome 6q and a Confirmation in an Independent Series of Pedigrees. Genomics. 43(1). 1–8. 172 indexed citations
7.
Daniel, L.N., et al.. (1995). DNA Strand Breakage, Thymine Glycol Production, and Hydroxyl Radical Generation Induced by Different Samples of Crystalline Silica in Vitro. Environmental Research. 71(1). 60–73. 43 indexed citations
8.
Uitti, Ryan J., Barry Snow, Hitoshi Shinotoh, et al.. (1994). Parkinsonism induced by solvent abuse. Annals of Neurology. 35(5). 616–619. 44 indexed citations
9.
Youdim, Moussa B. H., et al.. (1993). L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfish. European Journal of Pharmacology. 240(2-3). 185–193. 14 indexed citations
10.
Pollard, Harvey B., K R Dhariwal, Mark N. Levine, et al.. (1993). The Goldfish as a Drug Discovery Vehicle for Parkinson's Disease and Other Neurodegenerative Disorders. Annals of the New York Academy of Sciences. 679(1). 317–320. 7 indexed citations
11.
Markey, Sanford P., et al.. (1993). Gas chromatographic-mass spectrometric method for the assessment of oxidative damage to double-stranded dna by quantification of thymine glycol residues. Journal of the American Society for Mass Spectrometry. 4(4). 336–342. 3 indexed citations
12.
Youdim, Moussa B. H., K R Dhariwal, M.S. Levine, et al.. (1992). MPTP-induced “Parkinsonism” in the goldfish. Neurochemistry International. 20. 275–278. 10 indexed citations
13.
Ikeda, Hiroya, Carol Markey, & Sanford P. Markey. (1992). Search for neurotoxins structurally related to 1-methyl-4-phenylpyridine (MPP+) in the pathogenesis of Parkinson's disease. Brain Research. 575(2). 285–298. 32 indexed citations
14.
Pollard, Harvey B., et al.. (1992). A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP. The FASEB Journal. 6(12). 3108–3116. 47 indexed citations
15.
Johannessen, Jan N., et al.. (1987). I. The development of amine substituted analogues of MPTP as unique tools for the study of MPTP toxicity and Parkinson's disease. Life Sciences. 40(8). 697–704. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026